CSPC Pharmaceutical Group Limited (CSPCY)
Company Info
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - General |
Highlights
| Market Cap | $6.82B |
|---|---|
| EPS (TTM) | $0.28 |
| PE Ratio | 8.12 |
| PEG Ratio | 12.31 |
| Total Revenue (TTM) | $24.35B |
| Gross Profit (TTM) | $17.43B |
| EBITDA (TTM) | $5.99B |
| Year Range | $2.25 - $3.63 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in CSPC Pharmaceutical Group Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
CSPC Pharmaceutical Group Limited had a return of -36.89% year-to-date (YTD) and -18.86% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -36.89% | 17.95% |
| 1 month | -22.45% | 3.13% |
| 6 months | -31.31% | 9.95% |
| 1 year | -18.86% | 24.88% |
| 5 years (annualized) | -68.70% | 13.37% |
| 10 years (annualized) | N/A | 10.92% |
Monthly Returns
The table below presents the monthly returns of CSPCY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -21.52% | 5.32% | 1.97% | 4.18% | 5.87% | -7.40% | -6.24% | -17.56% | -36.89% | ||||
| 2023 | 10.56% | -5.56% | -9.34% | 3.57% | -14.00% | 1.37% | -3.21% | -10.84% | -0.65% | 19.16% | 3.22% | 4.53% | -5.78% |
| 2022 | 16.05% | -5.81% | -3.41% | -11.89% | 7.04% | -7.33% | 9.95% | -6.66% | -1.78% | 4.36% | 26.78% | -20.93% | -2.70% |
| 2021 | 10.40% | 0.23% | 7.17% | 6.45% | 23.03% | -4.75% | -4.75% | -8.58% | -4.40% | -12.84% | -1.33% | 5.26% | 11.49% |
| 2020 | 0.60% | -5.28% | -9.33% | -1.21% | -3.96% | -5.35% | -55.51% | 6.80% | -12.45% | -45.96% | -90.35% | -6.66% | -98.43% |
| 2019 | 41.61% | 0.00% | -17.32% | 22.34% | -0.39% | 25.78% | -11.46% | 5.06% | 66.95% | ||||
| 2018 | -54.28% | -54.28% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CSPCY is 25, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for CSPC Pharmaceutical Group Limited (CSPCY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
CSPC Pharmaceutical Group Limited granted a 3.14% dividend yield in the last twelve months. The annual payout for that period amounted to $0.07 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Dividend | $0.07 | $0.13 | $0.10 | $0.09 | $0.07 | $0.05 |
Dividend yield | 3.14% | 3.46% | 2.50% | 2.03% | 1.87% | 0.02% |
Monthly Dividends
The table displays the monthly dividend distributions for CSPC Pharmaceutical Group Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.07 | |||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.00 | $0.13 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.10 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.09 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.00 | $0.07 |
| 2019 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.05 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the CSPC Pharmaceutical Group Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CSPC Pharmaceutical Group Limited was 99.23%, occurring on Sep 10, 2024. The portfolio has not yet recovered.
The current CSPC Pharmaceutical Group Limited drawdown is 99.23%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.23% | Dec 24, 2018 | 978 | Sep 10, 2024 | — | — | — |
Volatility
Volatility Chart
The current CSPC Pharmaceutical Group Limited volatility is 18.86%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of CSPC Pharmaceutical Group Limited compared to its peers in the Drug Manufacturers - General industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for CSPCY in comparison to other companies of the Drug Manufacturers - General industry. Currently, CSPCY has a PE value of 8.1. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for CSPCY in comparison to other companies of the Drug Manufacturers - General industry. Currently, CSPCY has a PEG value of 12.3. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for CSPC Pharmaceutical Group Limited.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |